Singapore markets closed
Straits Times Index
3,313.48 +8.49 (+0.26%) Nikkei
38,787.38 -132.88 (-0.34%) Hang Seng
19,553.61 +177.08 (+0.91%) FTSE 100
8,420.26 -18.39 (-0.22%) Bitcoin USD
66,871.05 +1,462.27 (+2.24%) CMC Crypto 200
1,364.80 -9.04 (-0.66%)
TransMedics Group, Inc. (TMDX)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 134.93 |
| Open | 135.33 |
| Bid | 137.94 x 200 |
| Ask | 138.20 x 200 |
| Day's range | 134.51 - 139.93 |
| 52-week range | 36.42 - 139.93 |
| Volume | |
| Avg. volume | 957,209 |
| Market cap | 4.545B |
| Beta (5Y monthly) | 1.87 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.34 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 119.20 |
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that on May 14, 2024, TransMedics granted non-qualified stock options to purchase an aggregate of 18,320 shares of its common stock and an aggregate of 12,068 restricted stock units to 8 employees, each as a material inducement for each employee's entry into employment with TransMedics. The g
ZacksAre You Looking for a Top Momentum Pick? Why TransMedics (TMDX) is a Great Choice
Does TransMedics (TMDX) have what it takes to be a top stock pick for momentum investors? Let's find out.
GuruFocus.comInsider Sale: Director Edward Basile Sells Shares of TransMedics Group Inc (TMDX)
On May 7, 2024, Edward Basile, Director at TransMedics Group Inc (NASDAQ:TMDX), sold 7,157 shares of the company.
© 2024 Yahoo. All rights reserved.